Nada Babović

1.2k total citations
34 papers, 611 citations indexed

About

Nada Babović is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nada Babović has authored 34 papers receiving a total of 611 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 17 papers in Immunology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nada Babović's work include Immune Cell Function and Interaction (13 papers), T-cell and B-cell Immunology (10 papers) and CAR-T cell therapy research (9 papers). Nada Babović is often cited by papers focused on Immune Cell Function and Interaction (13 papers), T-cell and B-cell Immunology (10 papers) and CAR-T cell therapy research (9 papers). Nada Babović collaborates with scholars based in Serbia, United States and France. Nada Babović's co-authors include Katarina Mirjačić Martinović, Gordana Konjević, Vladimir Jurišić, Ana Vuletić, I Spuz̈ić, Radan Džodić, Vesna Jovanović, S Jelić, Vladimir Kovčin and S. Jelić and has published in prestigious journals such as Neurology, The Lancet Oncology and European Journal of Cancer.

In The Last Decade

Nada Babović

34 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nada Babović Serbia 14 319 258 114 98 66 34 611
Suzanne Fioravanti United States 12 261 0.8× 452 1.8× 71 0.6× 146 1.5× 68 1.0× 28 696
Hong Yi Wang United States 7 383 1.2× 531 2.1× 144 1.3× 175 1.8× 205 3.1× 12 791
Sumie Hiramatsu Japan 13 173 0.5× 143 0.6× 43 0.4× 100 1.0× 59 0.9× 37 477
David B. Page United States 5 285 0.9× 448 1.7× 73 0.6× 104 1.1× 32 0.5× 6 567
Manik Amin United States 15 119 0.4× 358 1.4× 103 0.9× 130 1.3× 48 0.7× 53 596
Birge Berns United Kingdom 6 285 0.9× 308 1.2× 45 0.4× 132 1.3× 38 0.6× 12 525
Eivind Smeland Norway 14 93 0.3× 231 0.9× 195 1.7× 98 1.0× 56 0.8× 22 441
Jithendra Kini Bailur United States 11 404 1.3× 563 2.2× 70 0.6× 156 1.6× 30 0.5× 16 771
M. Saunders United States 12 129 0.4× 143 0.6× 71 0.6× 71 0.7× 182 2.8× 24 506
Gabriel Prolla Brazil 8 118 0.4× 196 0.8× 43 0.4× 97 1.0× 158 2.4× 17 427

Countries citing papers authored by Nada Babović

Since Specialization
Citations

This map shows the geographic impact of Nada Babović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nada Babović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nada Babović more than expected).

Fields of papers citing papers by Nada Babović

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nada Babović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nada Babović. The network helps show where Nada Babović may publish in the future.

Co-authorship network of co-authors of Nada Babović

This figure shows the co-authorship network connecting the top 25 collaborators of Nada Babović. A scholar is included among the top collaborators of Nada Babović based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nada Babović. Nada Babović is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martinović, Katarina Mirjačić, Ana Vuletić, Suzana Matković, et al.. (2023). Circulating IL-6 is associated with disease progression in BRAFwt metastatic melanoma patients receiving anti-PD-1 therapy. Journal of Clinical Pathology. 77(5). 343–351. 9 indexed citations
2.
Martinović, Katarina Mirjačić, Ana Vuletić, Milica Nedeljković, et al.. (2023). Increased circulating monocyte MDSCs positively correlate with serum Interleukin-10 in metastatic melanoma patients. Innate Immunity. 29(3-4). 37–44. 7 indexed citations
3.
Martinović, Katarina Mirjačić, Ana Vuletić, Emina Mališić, et al.. (2022). Increased circulating TGF-β1 is associated with impairment in NK cell effector functions in metastatic melanoma patients. Growth Factors. 40(5-6). 231–239. 15 indexed citations
4.
5.
Vuletić, Ana, Gordana Konjević, Annette K. Larsen, et al.. (2020). Interleukin-4-induced natural killer cell antitumor activity in metastatic melanoma patients. European Cytokine Network. 31(3). 104–112. 13 indexed citations
6.
Martinović, Katarina Mirjačić, Tatjana Srdić‐Rajić, Nada Babović, et al.. (2015). Decreased expression of pSTAT, IRF-1 and DAP10 signalling molecules in peripheral blood lymphocytes of patients with metastatic melanoma. Journal of Clinical Pathology. 69(4). 300–306. 13 indexed citations
7.
Martinović, Katarina Mirjačić, Nada Babović, Radan Džodić, et al.. (2015). Favorable in vitro effects of combined IL-12 and IL-18 treatment on NK cell cytotoxicity and CD25 receptor expression in metastatic melanoma patients. Journal of Translational Medicine. 13(1). 120–120. 37 indexed citations
8.
Martinović, Katarina Mirjačić, Nada Babović, Radan Džodić, et al.. (2014). Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients. Melanoma Research. 24(4). 295–304. 46 indexed citations
9.
Konjević, Gordana, Katarina Mirjačić Martinović, Ana Vuletić, & Nada Babović. (2010). In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients. Melanoma Research. 20(6). 459–467. 32 indexed citations
10.
Konjević, Gordana, Katarina Mirjačić Martinović, Vladimir Jurišić, Nada Babović, & I Spuz̈ić. (2009). Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: Decreased NKG2D and increased CD158a receptors on CD3–CD16+ NK cells. Biomarkers. 14(4). 258–270. 50 indexed citations
11.
Bjelogrlić, Snežana, Siniša Radulović, & Nada Babović. (2008). Molecular Targeting Agents in Renal Cell Carcinoma: Present Strategies and Future Perspectives. Current Pharmaceutical Design. 14(11). 1058–1077. 6 indexed citations
12.
Konjević, Gordana, Katarina Mirjačić Martinović, Ana Vuletić, et al.. (2007). Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients. Clinical & Experimental Metastasis. 24(1). 1–11. 74 indexed citations
13.
Babovic‐Vuksanovic, Dusica, Karla V. Ballman, Virginia V. Michels, et al.. (2006). Phase II trial of pirfenidone in adults with neurofibromatosis type 1. Neurology. 67(10). 1860–1862. 51 indexed citations
14.
Babović, Nada, et al.. (2003). Antimelanoma immunity in vitiligo and melanoma patients.. PubMed. 50(4). 305–9. 3 indexed citations
15.
16.
17.
18.
Juranić, Zorica D., et al.. (1997). [Levels of immune complexes in fresh and frozen serum and plasma detected by precipitation with polyethylene glycol in patients with malignant diseases].. PubMed. 125(5-6). 154–6. 2 indexed citations
19.
Kovčin, Vladimir, et al.. (1997). Serum Gonadotropin Levels in Patients with Germ-Cell Tumors of the Testis: Interrelations, Possible Cross-Reactions and Interpretation of Beta-Hcg Level. The International Journal of Biological Markers. 12(2). 55–60. 2 indexed citations
20.
Jelić, S., et al.. (1988). Edta Clearance in Monitoring Cisplatin Dose Escalation in Patients with Bulky Metastatic Germ Cell Tumors of the Testis. Acta Oncologica. 27(5). 541–543. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suzanne Fioravanti Breakdown of academic impact, for papers by Hong Yi Wang Breakdown of academic impact, for papers by Sumie Hiramatsu Breakdown of academic impact, for papers by David B. Page Breakdown of academic impact, for papers by Manik Amin Breakdown of academic impact, for papers by Birge Berns Breakdown of academic impact, for papers by Eivind Smeland Breakdown of academic impact, for papers by Jithendra Kini Bailur Breakdown of academic impact, for papers by M. Saunders Breakdown of academic impact, for papers by Gabriel Prolla
Rankless by CCL
2026